Recon: Second patient death linked to Alzheimer’s drug lecanemab rocks Eisai, Biogen; Roche withdraws Tecentriq’s bladder cancer indication
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy